Anti-inflammatory circuitry: Lipoxin, aspirin-triggered lipoxins and their receptor ALX

Prostaglandins Leukotrienes and Essential Fatty Acids

Volumn 73, Issue 3-4, 2005, Pages 163-177

  Chiang, Nan ^a   Arita, Makoto ^a   Serhan, Charles N ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

15 HYDROXYICOSATETRAENOIC ACID; ACETYLSALICYLIC ACID; CYCLOOXYGENASE 2; GLUCOCORTICOID; ICOSANOID; LIPOXIN; LIPOXIN A; LIPOXIN B; LIPOXIN RECEPTOR; LIPOXYGENASE; PROSTAGLANDIN; THROMBOXANE;

ACETYLATION; ANTIINFLAMMATORY ACTIVITY; ASTHMA; BRAIN ISCHEMIA; CATALYSIS; CELL PROLIFERATION; CHEMICAL BOND; CHEMOTAXIS; CHRONIC LIVER DISEASE; CHRONIC MYELOID LEUKEMIA; CLINICAL TRIAL; DRUG ACTIVITY; ENZYME INACTIVATION; ENZYME INHIBITION; FATTY ACID SYNTHESIS; GENE CASSETTE; GLOMERULONEPHRITIS; GRAFT VERSUS HOST REACTION; HELMINTHIASIS; HUMAN; INFLAMMATION; LIGAND BINDING; LOW DRUG DOSE; MOLECULAR CLONING; MOLECULAR MECHANICS; NEUTROPHIL CHEMOTAXIS; NONHUMAN; PATHOPHYSIOLOGY; PERITONITIS; PHAGOCYTOSIS; PHYLOGENY; PLEURA DISEASE; POLYMORPHONUCLEAR CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; RESPIRATORY TRACT INFECTION; REVIEW; SEQUENCE HOMOLOGY; SIGNAL TRANSDUCTION; STEREOCHEMISTRY; THROMBOCYTE AGGREGATION; TOXOPLASMOSIS;

EID: 24344510350     PISSN: 09523278     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.plefa.2005.05.003     Document Type: Article

References (63)

1. C.N. Serhan Endogenous chemical mediators in anti-inflammation and pro-resolution Curr. Med. Chem. - Anti-Inflammatory Anti-Allergy Agents 1 2002 177 192
2. C. Nathan Points of control in inflammation Nature 420 2002 846 852
3. C.N. Serhan Lipoxin biosynthesis and its impact in inflammatory and vascular events Biochim. Biophys. Acta 1212 1994 1 25
4. A.J. Marcus Aspirin as prophylaxis against colorectal cancer N. Engl. J. Med. 333 1995 656 658
5. J.R. Vane, Adventures and excursions in bioassay: the stepping stones to prostacyclin. In: Les Prix Nobel: Nobel Prizes, Presentations, Biographies and Lectures, Almqvist & Wiksell, Stockholm, 1982, pp. 181-206.
6. J. Clària, and C.N. Serhan Aspirin triggers previously undescribed bioactive eicosanoids by human endothelial cell-leukocyte interactions Proc. Natl. Acad. Sci. USA 92 1995 9475 9479
7. C.N. Serhan, C.B. Clish, J. Brannon, S.P. Colgan, N. Chiang, and K. Gronert Novel functional sets of lipid-derived mediators with antiinflammatory actions generated from omega-3 fatty acids via cyclooxygenase 2-nonsteroidal antiinflammatory drugs and transcellular processing J. Exp. Med. 192 2000 1197 1204
8. C.N. Serhan, S. Hong, and K. Gronert Resolvins: a family of bioactive products of omega-3 fatty acid transformation circuits initiated by aspirin treatment that counter pro-inflammation signals J. Exp. Med. 196 2002 1025 1037
9. C.N. Serhan Lipoxins and novel aspirin-triggered 15-epi-lipoxins (ATL): a jungle of cell-cell interactions or a therapeutic opportunity? Prostaglandins 53 1997 107 137
10. 4 stable analogs that block transmigration and adhesion of human neutrophils Biochemistry 34 1995 14,609 14,615
11. 4 metabolic inactivation J. Biol. Chem. 275 2000 25,372 25,380
12. 4 analogs with increased biologic activity FASEB J. 12 1998 487 494
13. C.B. Clish, J.A. O'Brien, K. Gronert, G.L. Stahl, N.A. Petasis, and C.N. Serhan Local and systemic delivery of a stable aspirin-triggered lipoxin prevents neutrophil recruitment in vivo Proc. Natl. Acad. Sci. USA 96 1999 8247 8252
14. K.A. Munger, A. Montero, and M. Fukunaga Transfection of rat kidney with human 15-lipoxygenase suppresses inflammation and preserves function in experimental glomerulonephritis Proc. Natl. Acad. Sci. USA 96 1999 13375 13380
15. 4 accelerate resolution of allergic edema in Angiostrongylus costaricensis-infected rats: relationship with concurrent eosinophilia J. Immunol. 164 2000 1029 1036
16. 4 receptor transgenic mice reveal novel protective roles for lipoxins and aspirin-triggered lipoxins in reperfusion J. Clin. Invest. 104 1999 309 316
17. J. Aliberti, C. Serhan, and A. Sher Parasite-induced lipoxin A(4) is an endogenous regulator of IL-12 production and immunopathology in toxoplasma gondii infection J. Exp. Med. 196 2002 1253 1262
18. J. Aliberti, S. Hieny, C. Reis e Sousa, C.N. Serhan, and A. Sher Lipoxin-mediated inhibition of IL-12 production by DCs: a mechanism for regulation of microbial immunity Nat. Immunol. 3 2002 76 82
19. 4 ELISA J. Pharmacol. Exp. Ther. 287 1998 779 790
20. M. Perretti, N. Chiang, and M. La Endogenous lipid- and peptide-derived anti-inflammatory pathways generated with glucocorticoid and aspirin treatment activate the lipoxin A(4) receptor Nat. Med. 8 2002 1296 1302
21. 4 (ATL) Am. J. Physiol. 277 1999 C870 C877
22. S. Fiorucci, O.M. De Lima Jr., and A. Mencarelli Cyclooxygenase-2-derived lipoxin A4 increases gastric resistance to aspirin-induced damage Gastroenterology 123 2002 1598 1606
23. 4 analogues inhibit leukocyte recruitment to Porphyromonas gingivalis: a role for cyclooxygenase-2 and lipoxins in periodontal disease Biochemistry 39 2000 4761 4768
24. C. Bonnans, I. Vachier, C. Chavis, P. Godard, J. Bousquet, and P. Chanez Lipoxins are potential endogenous antiinflammatory mediators in asthma Am. J. Respir. Crit. Care Med. 165 2002 1531 1535
25. C.L. Karp, L.M. Flick, and K.W. Park Defective lipoxin-mediated anti-inflammatory activity in the cystic fibrosis airway Nat. Immunol. 5 2004 388 392
26. 4 and inhibits thromboxane in a randomized human trial Proc. Natl. Acad. Sci. USA 101 2004 15,178 15,183
27. 4 and fMLP in human neutrophils Exp. Cell Res. 300 2004 308 319
28. C. Godson, S. Mitchell, K. Harvey, N.A. Petasis, N. Hogg, and H.R. Brady Cutting edge: lipoxins rapidly stimulate nonphlogistic phagocytosis of apoptotic neutrophils by monocyte-derived macrophages J. Immunol. 164 2000 1663 1667
29. 4 analogs block extracellular signal-regulated kinase-dependent TNF-α secretion from human T cells J. Immunol. 170 2003 6266 6272
30. 4 receptor that is conserved in structure and function Br. J. Pharmacol. 139 2003 89 98
31. P.R. Devchand, B.A. Schmidt, and V.C. Primo A synthetic eicosanoid LX-mimetic unravels host-donor interactions in allogeneic BMT-induced GvHD to reveal an early protective role for host neutrophils FASEB J. 19 2005 203 210
32. P.R. Devchand, M. Arita, and S. Hong Human ALX receptor regulates neutrophil recruitment in transgenic mice: roles in inflammation and host-defense FASEB J. 17 2003 652 659
33. 4 inhibits IL-1 beta-induced IL-6, IL-8, and matrix metalloproteinase-3 production in human synovial fibroblasts and enhances synthesis of tissue inhibitors of metalloproteinases J. Immunol. 164 2000 2660 2666
34. M. Arita, F. Bianchini, and J. Aliberti Stereochemical assignment, anti-inflammatory properties, and receptor for the omega-3 lipid mediator resolvin E1 J. Exp. Med. 201 2005 713 722
35. 4 receptors by aspirin-triggered lipoxins and select peptides evokes ligand-specific responses in inflammation J. Exp. Med. 191 2000 1197 1207
36. S. Mitchell, G. Thomas, and K. Harvey Lipoxins, aspirin-triggered epi-lipoxins, lipoxin stable analogues, and the resolution of inflammation: stimulation of macrophage phagocytosis of apoptotic neutrophils in vivo J. Am. Soc. Nephrol. 13 2002 2497 2507
37. M. Resnati, I. Pallavicini, and J.M. Wang The fibrinolytic receptor for urokinase activates the G protein-coupled chemotactic receptor FPRL1/LXA4R Proc. Natl. Acad. Sci. USA 99 2002 1359 1364
38. Y. Le, P.M. Murphy, and J.M. Wang Formyl-peptide receptors revisited Trends Immunol. 23 2002 541 548
39. F.N. Gavins, S. Yona, A.M. Kamal, R.J. Flower, and M. Perretti Leukocyte antiadhesive actions of annexin 1: ALXR- and FPR-related anti-inflammatory mechanisms Blood 101 2003 4140 4147
40. P. Maderna, S. Yona, M. Perretti, and C. Godson Modulation of phagocytosis of apoptotic neutrophils by supernatant from dexamethasone-treated macrophages and annexin-derived peptide Ac(2-26) J. Immunol. 174 2005 3727 3733
41. 4 receptor that is regulated by IL-13 and IFN-γand inhibits TNF-α-induced IL-8 release J. Exp. Med. 187 1998 1285 1294
42. S. Mocellin, M. Panelli, and E. Wang IL-10 stimulatory effects on human NK cells explored by gene profile analysis Genes Immun. 5 2004 621 630
43. 4 FASEB J. 13 1999 903 911
44. L. Jozsef, C. Zouki, N.A. Petasis, C.N. Serhan, and J.G. Filep Lipoxin A4 and aspirin-triggered 15-epi-lipoxin A4 inhibit peroxynitrite formation, NF-kappa B and AP-1 activation, and IL-8 gene expression in human leukocytes Proc. Natl. Acad. Sci. USA 99 2002 13,266 13,271
45. P. Maderna, D.C. Cottell, G. Berlasconi, N.A. Petasis, H.R. Brady, and C. Godson Lipoxins induce actin reorganization in monocytes and macrophages but not in neutrophils: differential involvement of rho GTPases Am. J. Pathol. 160 2002 2275 2283
46. 4 analog blocks phosphorylation of leukocyte-specific protein 1 in human neutrophils J. Immunol. 173 2004 2091 2098
47. 4 inhibit human neutrophil migration: comparisons between synthetic 15 epimers in chemotaxis and transmigration with microvessel endothelial cells and epithelial cells J. Immunol. 170 2003 2688 2694
48. 4 up-regulate transcriptional corepressor NAB1 in human neutrophils FASEB J. 15 2001 2736 2738
49. 4 analogs J. Clin. Invest. 101 1998 1860 1869
50. 4 analogs attenuate induction of intestinal epithelial proinflammatory gene expression and reduce the severity of dextran sodium sulfate-induced colitis J. Immunol. 168 2002 5260 5267
51. P. Maderna, C. Godson, G. Hannify, M. Murphy, and H.R. Brady Influence of lipoxin A(4) and other lipoxygenase-derived eicosanoids on tissue factor expression Am. J. Physiol. Cell Physiol. 279 2000 C945 C953
52. B.D. Levy, C.B. Clish, B. Schmidt, K. Gronert, and C.N. Serhan Lipid mediator class switching during acute inflammation: signals in resolution Nat. Immunol. 2 2001 612 619
53. G.A. FitzGerald, and C. Patrono The coxibs, selective inhibitors of cyclooxygenase-2 N. Engl. J. Med. 345 2001 433 442
54. G.L. Bannenberg, N. Chiang, and A. Ariel Molecular circuits of resolution: formation and actions of resolvins and protectins J. Immunol. 174 2005 4345 4355
55. S.B. Su, W. Gong, and J.-L. Gao A seven-transmembrane, G protein-coupled receptor, FPRL1, mediates the chemotactic activity of serum amyloid A for human phagocytic cells J. Exp. Med. 189 1999 395 402
56. X. Deng, H. Ueda, and S.B. Su A synthetic peptide derived from human immunodeficiency virus type 1 gp120 downregulates the expression and function of chemokine receptors CCR5 and CXCR4 in monocytes by activating the 7-transmembrane G-protein-coupled receptor FPRL1/LXA4R Blood 94 1999 1165 1173
57. W. Shen, P. Proost, and B. Li Activation of the chemotactic peptide receptor FPRL1 in monocytes phosphorylates the chemokine receptor CCR5 and attenuates cell responses to selected chemokines Biochem. Biophys. Res. Commun. 272 2000 276 283
58. S.B. Su, J.I. Gao, and W. Gong T21/DP107, a synthetic leucine zipper-like domain of the HIV-1 envelope gp41, attracts and activates human phagocytes by using G-protein-coupled formyl peptide receptors J. Immunol. 162 1999 5924 5930
59. Y. Le, S. Jiang, and J. Hu N36, a synthetic N-terminal heptad repeat domain of the HIV-1 envelope protein gp41, is an activator of human phagocytes Clin. Immunol. 96 2000 236 242
60. 4 receptor Blood 95 2000 1810 1818
61. D. Yang, Q. Chen, and A.P. Schmidt LL-37, the neutrophil granule- and epithelial cell-derived cathelicidin, utilizes formyl peptide receptor-like 1 (FPRL1) as a receptor to chemoattract human peripheral blood neutrophils, monocytes, and T cells J. Exp. Med. 192 2000 1069 1074
62. 42 activates a G-protein-coupled chemoattractant receptor, FPR-like-1 J. Neurosci. 21 2001 1 5
63. Y. Le, H. Yazawa, and W. Gong The neurotoxic prion peptide fragment PrP(106-126) is a chemotactic agonist for the G protein-coupled receptor formyl peptide receptor-like 1 J. Immunol. 166 2001 1448 1451